Pipeline
Gene therapy hereditary diseases
Genotarget develops and implements genetherapeutic drugs
for the treatment of orphan neuromuscular diseases
for the treatment of orphan neuromuscular diseases
GT FP 101
LGMD R9
FKRP
GT CN 101
Calpainopathy
LGMD R1
CAPN3
GT DF 102
Dysferlinopathy
LGMD R2
DYSF
Gen
Gen
Gen
Development
Preclinical trials
Clinical trials
Access
to the market
to the market
Proof
of Concept
of Concept
"LLC" Genotarget - resident of the "Biomed" cluster of the Skolkovo Foundation
The work is supported by a grant from the Skolkovo Foundation.
Contact
Moscow, 121614
st. Krylatskie Hills, 32 bldg. 2,
room 4/1, room. 6, office 14
Mailing address :
Moscow, Vernadskogo Avenue 96
st. Krylatskie Hills, 32 bldg. 2,
room 4/1, room. 6, office 14
Mailing address :
Moscow, Vernadskogo Avenue 96
mail@genotarget.com
